| Literature DB >> 215305 |
G D Marshall, T L Low, G B Thurman, S K Hu, J L Rossio, G Trivers, A L Goldstein.
Abstract
Our current research program centers around the biologic and chemical characterization of the family of polypeptides present in thymosin fraction 5. A system of nomenclature has been developed and the peptides are being systematically isolated and chemically characterized. Thymosin fraction 5 and its component parts influence a variety of lymphocyte properties including cyclic nucleotide levels, migration inhibitory factor production, T-dependent antibody production, and expression of certain surface markers. Thymosin is being used in clinical trials to investigate its effects on immunodeficiency diseases, malignant diseases, and autoimmune diseases.Entities:
Mesh:
Substances:
Year: 1978 PMID: 215305
Source DB: PubMed Journal: Cancer Treat Rep ISSN: 0361-5960